PRZOOM - /newswire/ -
Goole, East Yorkshire, United Kingdom, 2011/06/27 - Croda is honoured to be the first raw material supplier to have a range of ingredients recognised by the British Skin Foundation (BSF).
Medilan is the trade mark for Croda’s medical grade lanolin and the product that Croda was founded on back in 1925. It is a unique natural emollient, used widely in cosmetics and medicated skin care products to augment the functions of the human skin lipids. By replenishing the essential lipids of the skin, Medilan is able to accelerate the repair of the skin’s natural barrier function, whilst simultaneously protecting against microbial infection.
To achieve such recognition, the BSF has independently validated the vast research Croda has undertaken on its Medilan range to ensure that Medilan delivers the skin health benefits it is renowned for. The assessment was conducted by three leading UK dermatologists, who reviewed a dossier detailing the composition, manufacture and research linked to the skin care ingredient.
Matthew Patey, CEO of British Skin Foundation commented ‘Having reviewed the extensive research dossiers and personally interviewed Croda’s R&D team, BSF representative dermatologists concluded that Medilan fulfils its stated objectives and, above all, is not detrimental to skin health. In addition, the panel appreciate Croda’s extensive research heritage in the lanolin field. The British Skin Foundation is therefore delighted to award Medilan its badge of research recognition.’
‘After dedicating decades to research and developing clinical data in the area of lanolin, it is great to see that Croda’s Medilan range has been recognised in this way’, said Laura Kelly, Marketing Manager of Croda Health Care, ‘BSF is demanding in the level of detail they requested on the Medilan range, but with a wealth of research in this area we felt confident that such recognition would be achieved.’
British Skin Foundation
The British Skin Foundation is a registered charity dedicated to raising funds for skin disease and skin cancer research. Its mission is to fund work that may lead to new treatments and eventually cures for the many skin diseases that devastate millions of lives. For media enquiries the British Skin Foundation and the work they do, please contact Bevis Man at bevis[.]bad.org.uk.
Croda (croda.com) is a global leader in speciality chemicals sold to a wide range of industries. The Croda Health Care division provides high quality ingredients for dermatological, pharmaceutical and nutritional markets, with particular expertise in skin science. High investment in GMP, new technologies and R&D ensures Croda are well positioned for the continual delivery of exceptional skin care ingredients.
The Medilan brand
Croda’s Medilan range of lanolin products offer exceptional purity, beyond that of monograph compliance, and unrivalled performance in clinical trials. The pure and hypoallergenic properties deliver outstanding efficacy in dermatological applications, as well as proved safety in use. Clinical trials have demonstrated that the Medilan range brings a number of functional advantages to modern treatments.
Alternatively, we will be exhibiting at the British Association of Dermatology in London, 5th-7th July.